Abstract:Background Alzheimer's disease and related dementias (ADRD) and Parkinson's disease (PD) are the most common neurodegenerative conditions. These central nervous system disorders impact both the structure and function of the brain and may lead to imaging changes that precede symptoms. Patients with ADRD or PD have long asymptomatic phases that exhibit significant heterogeneity. Hence, quantitative measures that can provide early disease indicators are necessary to improve patient stratification, clinical care, and clinical trial design. This work uses machine learning techniques to derive such a quantitative marker from T1-weighted (T1w) brain Magnetic resonance imaging (MRI). Methods In this retrospective study, we developed machine learning (ML) based disease-specific scores based on T1w brain MRI utilizing Parkinson's Disease Progression Marker Initiative (PPMI) and Alzheimer's Disease Neuroimaging Initiative (ADNI) cohorts. We evaluated the potential of ML-based scores for early diagnosis, prognosis, and monitoring of ADRD and PD in an independent large-scale population-based longitudinal cohort, UK Biobank. Findings 1,826 dementia images from 731 participants, 3,161 healthy control images from 925 participants from the ADNI cohort, 684 PD images from 319 participants, and 232 healthy control images from 145 participants from the PPMI cohort were used to train machine learning models. The classification performance is 0.94 [95% CI: 0.93-0.96] area under the ROC Curve (AUC) for ADRD detection and 0.63 [95% CI: 0.57-0.71] for PD detection using 790 extracted structural brain features. The most predictive regions include the hippocampus and temporal brain regions in ADRD and the substantia nigra in PD. The normalized ML model's probabilistic output (ADRD and PD imaging scores) was evaluated on 42,835 participants with imaging data from the UK Biobank. There are 66 cases for ADRD and 40 PD cases whose T1 brain MRI is available during pre-diagnostic phases. For diagnosis occurrence events within 5 years, the integrated survival model achieves a time-dependent AUC of 0.86 [95% CI: 0.80-0.92] for dementia and 0.89 [95% CI: 0.85-0.94] for PD. ADRD imaging score is strongly associated with dementia-free survival (hazard ratio (HR) 1.76 [95% CI: 1.50-2.05] per S.D. of imaging score), and PD imaging score shows association with PD-free survival (hazard ratio 2.33 [95% CI: 1.55-3.50]) in our integrated model. HR and prevalence increased stepwise over imaging score quartiles for PD, demonstrating heterogeneity. As a proxy for diagnosis, we validated AD/PD polygenic risk scores of 42,835 subjects against the imaging scores, showing a highly significant association after adjusting for covariates. In both the PPMI and ADNI cohorts, the scores are associated with clinical assessments, including the Mini-Mental State Examination (MMSE), Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog), and pathological markers, which include amyloid and tau. Finally, imaging scores are associated with polygenic risk scores for multiple diseases. Our results suggest that we can use imaging scores to assess the genetic architecture of such disorders in the future. Interpretation Our study demonstrates the use of quantitative markers generated using machine learning techniques for ADRD and PD. We show that disease probability scores obtained from brain structural features are useful for early detection, prognosis prediction, and monitoring disease progression. To facilitate community engagement and external tests of model utility, an interactive app to explore summary level data from this study and dive into external data can be found here https://ndds-brainimaging-ml.streamlit.app. As far as we know, this is the first publicly available cloud-based MRI prediction application. Funding US National Institute on Aging, and US National Institutes of Health.

Can we predict sleep health based on brain features? A large-scale machine learning study

Sleep Disturbance-Related Neuroimaging Features As Potential Biomarkers for the Diagnosis of Major Depressive Disorder: A Multicenter Study Based on Machine Learning

Predicting sex, age, general cognition and mental health with machine learning on brain structural connectomes

Prediction of depressive symptoms severity based on sleep quality, anxiety, and gray matter volume: a generalizable machine learning approach across three datasets

Predicting long-term sleep deprivation using wearable sensors and health surveys

0425 Detecting Insomnia and Predicting Difficulty Falling Asleep: Machine Learning of Heart Rate Data During Sleep Onset

The predictive value of supervised machine learning models for insomnia symptoms through smartphone usage behavior

Individualised prediction of resilience and vulnerability to sleep loss using EEG features

A multidimensional investigation of sleep and biopsychosocial profiles with associated neural signatures

Predicting Alzheimer's disease CSF core biomarkers: a multimodal Machine Learning approach

Multidimensional Sleep Profiles via Machine learning and Risk of Dementia and Cardiovascular Disease

Predictive Modelling of Stress Levels During Sleep using Machine learning

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer's Prevention

Application of Machine Learning to Sleep Stage Classification

A Brain Connectome Biomarker for Sleep Health

Classification and prediction of cognitive performance differences in older age based on brain network patterns using a machine learning approach

Sleep Quality Prediction From Wearable Data Using Deep Learning

Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imaging

Machine learning approach to investigate pregnancy and childbirth risk factors of sleep problems in early adolescence: Evidence from two cohort studies

Comparison of model feature importance statistics to identify covariates that contribute most to model accuracy in prediction of insomnia

0867 Machine Learning Analysis of Polysomnography Variables to Predict Hypertension